Blood Bank, Hospital Universitari I Politècnic La Fe, Valencia, Spain.
CIBERONC, Instituto Carlos III, Madrid, Spain.
Eur J Haematol. 2019 Sep;103(3):172-177. doi: 10.1111/ejh.13270. Epub 2019 Jul 3.
Umbilical cord blood transplantation (UCBT) and haploidentical hematopoietic stem cell transplantation (haplo-HSCT) modalities have been developed to offset the lack of matched donors. In this study, we compare the transfusion requirements of patients undergoing UCBT and haplo-HSCT in a single institution with the aim of providing additional information for clinicians to choose the most adequate alternative graft for HSCT.
The study reviewed 67 and 46 patients undergoing UCBT and haplo-HSCT, respectively.
There were no significant differences for RBC and PLT requirements according to the transplantation modality. Median time to RBC transfusion independence was 35 and 25.5 days in patients who received an UCBT and haplo-HSCT, respectively (P = 0.38), while median time to platelet transfusion independence was 31 days for UCBT patients and 23 for haplo-HSCT patients (P < 0.001). Days until neutrophils > 0.5 × 10 /L were the only variable that significantly influenced RBC and PLT requirements for both transplantation modalities. Cumulative incidence of RBC and PLT transfusion independence at 90 days after transplantation was similar for both UCBT and haplo-HSCT.
Both transplantation platforms require prolonged and intensive supportive RBC and PLT transfusion therapy. Both transplantation platforms require prolonged and intensive supportive RBC and PLT transfusion therapy.
为了弥补匹配供体的缺乏,开发了脐带血移植(UCBT)和单倍体造血干细胞移植(haplo-HSCT)。本研究比较了单中心接受 UCBT 和 haplo-HSCT 的患者的输血需求,旨在为临床医生提供更多信息,选择最适合 HSCT 的替代移植物。
本研究分别回顾了 67 例和 46 例接受 UCBT 和 haplo-HSCT 的患者。
根据移植方式,RBC 和 PLT 的需求没有显著差异。接受 UCBT 和 haplo-HSCT 的患者 RBC 输血独立的中位时间分别为 35 天和 25.5 天(P=0.38),而血小板输血独立的中位时间分别为 UCBT 患者的 31 天和 haplo-HSCT 患者的 23 天(P<0.001)。中性粒细胞>0.5×10/L 的天数是唯一显著影响两种移植方式 RBC 和 PLT 需求的变量。移植后 90 天 RBC 和 PLT 输血独立的累积发生率在 UCBT 和 haplo-HSCT 之间相似。
两种移植平台均需要长期和强化的支持性 RBC 和 PLT 输血治疗。